Ferritin-based Disruptor Nanoparticles: A Novel Strategy to Enhance LDL Cholesterol Clearance Via Multivalent Inhibition of PCSK9-LDL Receptor Interaction.

Alessio Incocciati,Chiara Cappelletti,Silvia Masciarelli,Francesca Liccardo,Roberta Piacentini,Alessandra Giorgi,Lucia Bertuccini,Barbara De Berardis, Francesco Fazi,Alberto Boffi,Alessandra Bonamore,Alberto Macone

PROTEIN SCIENCE（2024）

引用 0|浏览5
暂无评分
关键词
alirocumab,evolocumab,ferritin,HepG2 cell line,hypercholesterolemia,LDL cholesterol,LDL receptor,PCSK9,protein nanoparticles,therapeutic peptides
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要